title: Impact of an oncogeriatric consulting team on therapeutic decision-making.
abstract: Increased life expectancy and cancer incidence imply the need to develop a specialized care policy for elderly patients with cancer. We created an oncogeriatric consulting team (OGCT) in Toulouse University Hospital to carry out comprehensive gerontological assessment at the bedside of hospitalized patients. We analyze the impact on the final cancer treatment decision of this mobile geriatric assessment. We carried out a descriptive, retrospective real-life analysis of a patient cohort over a two-year period. The OGCT assessed 124 patients, of whom the majority were women (54.8%), median age 81 years, living at home (95.2%) and with family caregivers (86.5%). Nearly all were frail (96.7% according to the classification of Balducci and colleagues) and 3.2% were vulnerable. The team's decisions were analyzed for patients who had not yet been treated (n=107). After analysis, the team's proposal was in line with the initial cancer treatment plan in 68.2% of cases (n=73). In cases where there was a disagreement, the final decision was in line with the mobile team's proposal in 17.75% of 107 patients (n=19). The decision of the team was followed more often when their assessment proposed strictly palliative treatment. The decision to give elderly patients specific cancer treatment seems in our experience rather to be a matter for the oncologists, and is not very susceptible to modification by geriatric opinion. On the other hand, the geriatrician appears to be more credible and his/her opinion more likely to be followed when the patient is considered too frail and less aggressive, or even exclusively palliative, treatment is proposed.
authors: Département Universitaire de Médecine Générale, Faculté Toulouse Rangueil, Toulouse, France. marieeve.rouge-bugat@dumg-toulouse.fr
authors: M E
authors: ME
authors: Rougé-Bugat
authors: S
authors: S
authors: Gérard
authors: L
authors: L
authors: Balardy
authors: O
authors: O
authors: Beyne-Rauzy
authors: N
authors: N
authors: Boussier
authors: A
authors: A
authors: Perrin
authors: S
authors: S
authors: Oustric
authors: B
authors: B
authors: Vellas
authors: F
authors: F
authors: Nourhashémi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D017028:Caregivers; D015331:Cohort Studies; D003657:Decision Making; D005260:Female; D016330:Frail Elderly; D015577:Geriatric Assessment; D006760:Hospitalization; D006785:Hospitals, University; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000628:therapy*; D010166:Palliative Care; D010348:Patient Care Team; D012017:Referral and Consultation; D012189:Retrospective Studies
references: J Psychiatr Res. 1975 Nov;12(3):189-98
references: 1202204
references: Crit Rev Oncol Hematol. 2011 May;78(2):138-49
references: 20444620
references: J Clin Oncol. 2007 May 10;25(14):1936-44
references: 17488994
references: Aging (Milano). 2001 Oct;13(5):395-405
references: 11820714
references: Cancer J. 2005 Nov-Dec;11(6):437-41
references: 16393477
references: Cancer. 2009 Oct 1;115(19):4547-53
references: 19562776
references: Lancet Oncol. 2009 Jan;10(1):80-7
references: 19111248
references: J Am Geriatr Soc. 1997 Jun;45(6):735-8
references: 9180669
references: Crit Rev Oncol Hematol. 2011 Feb;77(2):148-61
references: 20353897
references: Am J Surg. 2012 Aug;204(2):139-43
references: 22178483
references: J Cancer Res Clin Oncol. 2011 Apr;137(4):733-8
references: 20602238
references: Prog Urol. 2008 Nov;18 Suppl 7:S415-25
references: 19070825
references: Ann Oncol. 2012 Aug;23(8):2166-2172
references: 22250183
references: Crit Rev Oncol Hematol. 2003 Jun;46(3):211-20
references: 12791420
references: Gerontologist. 1975 Apr;15(2):100-3
references: 1120577
references: Trans R Soc Trop Med Hyg. 1996 May-Jun;90(3):223-7
references: 8758055
references: Cancer Control. 1994 Mar;1(2):132-137
references: 10886961
references: CA Cancer J Clin. 2010 Mar-Apr;60(2):120-32
references: 20173172
references: J Nutr Health Aging. 2011 Aug;15(8):667-70
references: 21968862
references: JAMA. 1963 Sep 21;185:914-9
references: 14044222
references: J Nutr Health Aging. 2006 Nov-Dec;10(6):456-63; discussion 463-5
references: 17183418
references: Crit Rev Oncol Hematol. 2011 Jan;77(1):63-9
references: 20116276
references: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references: 19474385
references: Crit Rev Oncol Hematol. 2008 Feb;65(2):156-63
references: 18082416
references: Gerontologist. 1969 Autumn;9(3):179-86
references: 5349366
references: Rev Neurol (Paris). 2005 Dec;161(12 Pt 1):1205-12
references: 16340916
references: Crit Rev Oncol Hematol. 2002 Mar;41(3):343-7
references: 11880210
references: Crit Rev Oncol Hematol. 2004 Nov;52(2):127-33
references: 15501077
references: Rev Med Interne. 2003 Dec;24(12):763-5
references: 14656633
references: J Clin Oncol. 2007 May 10;25(14):1876-81
references: 17488986
references: J Clin Oncol. 2011 Sep 20;29(27):3636-42
references: 21709194
references: Lancet. 1993 Oct 23;342(8878):1032-6
references: 8105269
references: Crit Rev Oncol Hematol. 2011 Aug;79(2):205-12
references: 20709565
references: Crit Rev Oncol Hematol. 2000 Sep;35(3):161-79
references: 10960799
references: JAMA. 1988 Apr 22-29;259(16):2450-2
references: 3280847
references: Crit Rev Oncol Hematol. 2011 Aug;79(2):196-204
references: 20655243
references: Lancet. 1990 Apr 28;335(8696):1020-2
references: 1970072
references: J Gerontol A Biol Sci Med Sci. 2008 Jul;63(7):724-30
references: 18693227
references: Crit Rev Oncol Hematol. 2010 Dec;76(3):208-17
references: 20005123
references: Cancer Control. 2003 Nov-Dec;10(6):440-1
references: 14652519
references: Crit Rev Oncol Hematol. 2007 Oct;64(1):1-9
references: 17613243
references: Rev Epidemiol Sante Publique. 2008 Jun;56(3):159-75
references: 18547762
references: J Clin Epidemiol. 1994 Nov;47(11):1245-51
references: 7722560
references: J Gerontol A Biol Sci Med Sci. 2008 May;63(5):518-22
references: 18511757